| Literature DB >> 29333674 |
Coline Jumeaux1, Olov Wahlsten2, Stephan Block2,3, Eunjung Kim1, Rona Chandrawati1,4, Philip D Howes1, Fredrik Höök2, Molly M Stevens1.
Abstract
Membrane fusion is a process of fundamental importance in biological systems that involves highly selective recognition mechanisms for the trafficking of molecular and ionic cargos. Mimicking natural membrane fusion mechanisms for the purpose of biosensor development holds great potential for amplified detection because relatively few highly discriminating targets lead to fusion and an accompanied engagement of a large payload of signal-generating molecules. In this work, sequence-specific DNA-mediated liposome fusion is used for the highly selective detection of microRNA. The detection of miR-29a, a known flu biomarker, is demonstrated down to 18 nm within 30 min with high specificity by using a standard laboratory microplate reader. Furthermore, one order of magnitude improvement in the limit of detection is demonstrated by using a novel imaging technique combined with an intensity fluctuation analysis, which is coined two-color fluorescence correlation microscopy.Entities:
Keywords: FRET; biosensors; liposomes; membrane fusion; nucleic acids
Mesh:
Substances:
Year: 2018 PMID: 29333674 PMCID: PMC5861668 DOI: 10.1002/cbic.201700592
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164
Figure 1Schematic illustration for the process of miRNA detection based on the promotion of DNA‐mediated liposome fusion. Target miRNA (red strand) is complementary to the hairpin (green strand) and hybridizes to it; this displacement reveals the sticky end of ds‐A/B. In the presence of target miRNA, liposome fusion is promoted by ds‐A/B and ds‐C/D hybridizing in a zipper‐like manner, which results in an increase in FRET signal. In the absence of target miRNA, liposome fusion is inhibited because hairpin DNA remains hybridized on ds‐A/B and no FRET increase is observed.
Figure 2Evaluation of the sensitivity of the DNA‐mediated liposome fusion assay for miR‐29a detection: A) Evolution of the FRET signals over time showing the kinetics of DNA‐mediated liposome fusion in the presence of different concentrations of target miR‐29a (1 T corresponds to 2.1×10−7 m), and B) corresponding dose–response curve obtained after 30 min of mixing DiI‐ and DiD‐labeled DNA‐functionalized liposomes (n=3). Error bars represent standard deviation.
Figure 3Evaluation of the specificity of the DNA‐mediated liposome fusion assay for miR‐29a detection: A) Evolution of the FRET signals over time showing the kinetics of DNA‐mediated liposome fusion in the presence of various miRNA sequences at a concentration of 2.1×10−7 m. B) Corresponding bar chart representing the FRET ratio values relative to the control for each miRNA sequence 30 min after mixing DiI‐ and DiD‐labeled DNA‐functionalized liposomes. n=3, * p<0.05 (ANOVA followed by Tukey post‐hoc test). Error bars represent standard deviation.
Figure 4A) The I r(t)/I g(t) ratio of the total intensity of the red channel over the green channel. B) Representative autocorrelation functions of I r(t)/I g(t)−γ (with γ=0.065 as the average bleed‐through factor), for miR‐29a concentrations indicated (1 T corresponds to 7.2×10−10 m). C) Dose–response curve obtained by using the two‐color fluorescence correlation microscopy setup (averaged over three independent sample sets, covering at least five measurements each). Error bars represent SEM. See Section S7 in the Supporting Information for details of the entire process.